Robert W. Ross is Chief Executive Officer of Surface Oncology, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Xilio Therapeutics, Inc.
17 Jun 24
4
Surface Oncology, Inc.
8 Sep 23
4
Surface Oncology, Inc.
11 Aug 23
4
Xilio Therapeutics, Inc.
13 Jun 23
4
Surface Oncology, Inc.
3 Mar 23
4
Surface Oncology, Inc.
5 Aug 22
4
Xilio Therapeutics, Inc.
17 Jun 22
3
Xilio Therapeutics, Inc.
17 Jun 22
4
Surface Oncology, Inc.
3 Mar 22
4
Surface Oncology, Inc.
14 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.02 | 25,000 | 25.50 k | 25,000 |
8 Sep 23 | SURF Surface Oncology | Common Stock | Sale back to company | Dispose D | No | No | 0 | 83,193 | 0.00 | 0 |
8 Sep 23 | SURF Surface Oncology | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 400,000 | 276.00 k | 0 |
1 Aug 23 | SURF Surface Oncology | Common Stock | Sell | Dispose S | No | No | 0.94 | 16,713 | 15.71 k | 83,193 |
12 Jun 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.8 | 13,200 | 36.96 k | 13,200 |
1 Mar 23 | SURF Surface Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 0.69 | 400,000 | 276.00 k | 400,000 |